Well Lead Med Co Ltd

Price Chart

Risk-Adjusted Performance

Well Lead Med Co Ltd (603309) Price Performance

Well Lead Med Co Ltd (603309) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at CNY13.06, down 9.37% from the previous close.

Over the past year, 603309 has traded between a low of CNY11.45 and a high of CNY15.77. The stock has gained 13.4% over this period. It is currently 17.2% below its 52-week high.

Well Lead Med Co Ltd has a market capitalization of $4.46B, with a price-to-earnings ratio of 18.41 and a dividend yield of 4.48%.

About Well Lead Med Co Ltd

Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guide wires, ureteral stent, urethral and ureteral dilation, and stone retrieval basket; anesthesia products, comprising endotracheal tubes, intubation accessories, laryngeal masks, endobronchial and tracheostomy tubes, anesthesia breathing circuits and accessories, and nasopharyngeal and oropharyngeal airway products. The company also offers respiratory products, including oxygen and aerosol therapy products, and capnography mask and cannula products; drainage/suction/gastroenterology products, such as drainage systems, Yankauer handles, suction catheters, and stomach and feeding tubes; hemodialysis blood tubing set; home care products, including male external catheter and convicath intermittent catheter; and ambulatory infusion pump for pain management. Well Lead Medical Co., Ltd. was founded in 1998 and is based in Guangzhou, China.

Compare Well Lead Med Co Ltd

Side-by-side comparison against top Healthcare peers.